Watanabe, Hirotoshi
Morimoto, Takeshi
Shiomi, Hiroki
Yoshikawa, Yusuke
Kato, Takao
Saito, Naritatsu
Shizuta, Satoshi
Ono, Koh
Yamaji, Kyohei
Ando, Kenji
Kaji, Shuichiro
Furukawa, Yutaka
Akao, Masaharu
Ishikawa, Tetsuya
Tamura, Takashi
Yamamoto, Yoshito
Muramatsu, Toshiya
Suwa, Satoru
Nakagawa, Yoshihisa
Kadota, Kazushige
Takatsu, Yoshiki
Nishikawa, Hideo
Hiasa, Yoshikazu
Hayashi, Yasuhiko
Miyazaki, Shunichi
Kimura, Takeshi
Clinical trials referenced in this document:
Documents that mention this clinical trial
Mortality impact of post-discharge myocardial infarction size after percutaneous coronary intervention: a patient-level pooled analysis from the 4 large-scale Japanese studies
https://doi.org/10.1007/s12928-018-0517-x
Safety and efficacy of everolimus- versus sirolimus-eluting stents: A systematic review and meta-analysis of 11 randomized trials
https://doi.org/10.1016/j.ahj.2012.08.007
Documents that mention this clinical trial
Mortality impact of post-discharge myocardial infarction size after percutaneous coronary intervention: a patient-level pooled analysis from the 4 large-scale Japanese studies
https://doi.org/10.1007/s12928-018-0517-x
Funding for this research was provided by:
Johnson and Johnson K.K.
Pharmaceuticals and Medical Devices Agency
Abbott Vascular Japan
Terumo
Article History
Received: 1 October 2017
Accepted: 25 February 2018
First Online: 5 March 2018
Compliance with ethical standards
:
: T. Kimura reports position as an advisory board member of Terumo Japan and Abbott Vascular. The other authors report no disclosures with regard to the content of this manuscript.